Patent · US Active

Aminoquinazoline and pyridopyrimidine derivatives

US9855269B2 · kind B2 · utility

0Cited by
2References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 9, 2017
Grant dateJan 2, 2018
Priority date
Expiry dateMar 9, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides a method of inhibiting angiogenesis in a patient by administering a compound of formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.